加拿大卫生部采用了新的药物安全准则,利用风险管理计划加强病人的安全。 Health Canada introduces new drug safety guidelines using Risk Management Plans to enhance patient safety.

加拿大卫生部提出了一项新的准则,使用风险管理计划来查明和管理对新药物的不利反应,目的是尽量减少对病人的伤害。 Health Canada introduces a new guideline using Risk Management Plans (RMPs) to identify and manage adverse reactions to new drugs, aiming to minimize patient harm. 该准则强调使用关系风险分析(ReRA)来建立一个系统风险结构,以更好地了解和减轻风险。 The guideline emphasizes using Relational Risk Analysis (ReRA) to build a System Risk Structure to better understand and mitigate risks. ReRA帮助确定病人对不利反应和适当治疗的反应,目的是在治疗开发和使用期间加强病人的安全。 ReRA helps in identifying patient responses to adverse reactions and appropriate treatments, with the goal of enhancing patient safety during therapy development and use.